LONA

LeonaBio, Inc.

Latest Form 4:Sale$5KbyRenninger Robert (CHIEF FINANCIAL OFFICER) · filed Mar 5, 2026

LeonaBio, Inc. (LONA) has 5 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Mar 5, 2026.

  • Industry:Biotechnology
  • CEO:Mark J. Litton
  • Employees:19
  • HQ:Bothell, WA, US
  • IPO:2020-09-18

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$56K

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Source
Sale$5KMar 5SEC ↗
Sale$7KMar 5SEC ↗
Sale$28KMar 5SEC ↗
Sale$9KMar 5SEC ↗
Sale$7KMar 5SEC ↗

Related companies

LeonaBio, Inc. is in the Healthcare sector.